Bolt Biotherapeutics, Inc. earnings per share and revenue

BOLT earnings per share for the last quarter are -0.56 USD whereas the estimation was -0.44 USD which accounts for -27.85% surprise. Company revenue for the same period amounts to 1.27 M USD despite the estimated figure of 1.01 M USD. Estimated earnings per share for the next quarter are -0.34 USD, and revenue is expected to reach 1.25 M USD. Also watch annual changes over time to get a bigger picture of BOLT earnings per share and revenue dynamics.